Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

Novel TB diagnostics paper to be presented at ECCMID 2022

Date: 23-26 April 2022

Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022
ECCMID conference

The 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022), taking place in Lisbon, Portugal from April 23-26 will be a hybrid event for the first time, so hopefully even more people will be able to attend this prestigious conference.

We are delighted that Jee-Whang Kim of the Leicester Tuberculosis Research Group (LTBRG) will be presenting a paper in the ‘Hot topics in tuberculosis’ session at 13:30 -14:30 on Tuesday 26th April.

The paper is called: “A novel bacteriophage-based assay stratifies tuberculosis risk in recent household contacts of pulmonary tuberculosis: a prospective observational cohort study’

The paper builds on a pilot study by Dr Pranab Haldar, Clinical Senior Lecturer (University of Leicester) and Dr Ben Swift, Director of Research and Development at PBD Biotech with others, that showed the potential of Actiphage as diagnostic for patients with active and incipient TB.

LTBRG is a group of scientists and academic clinicians focused on the discovery, development and implementation of knowledge to overcome the health, economic and social impact of tuberculosis (TB) at a local, national and global level.

https://www.eccmid.org/

Share:
  • Actiphage, Events

Related posts

Loading...
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN UK Phage Innovation Showcase will be Actiphage®, a phage-based molecular diagnostic for tuberculosis.
Actiphage TB diagnostic releases bacterial DNA for qPCR

16 May 2023

New Centre for Phage Research features Actiphage within Innovation Showcase

May 12, 2023
The UK’s first Centre for Phage Research is being officially launched on 16th May and featured in the UK KTN...
AACC Conference 2023 PBD booth 4578

23 - 27 July 2023

AACC Annual Scientific Meeting – Actiphage on booth 4578

April 14, 2023
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be an opportunity to find out more about phage-based diagnostics.
AACC Conference 2023 PBD booth 4578

23 - 27 July 2023

AACC Annual Scientific Meeting – Actiphage on booth 4578

April 14, 2023
The 2023 AACC Annual Scientific Meeting & Clinical Lab Expo will be an opportunity to find out more about phage-based...
Microbiology Society M logo

17-20 April 2023

Microbiology Society Conference 2023 Tuberculosis: The forgotten pandemic

April 12, 2023
The Microbiology Society Annual Conference 2023 will take place 17 -20 April 2023 at Birmingham International Convention Centre.
Microbiology Society M logo

17-20 April 2023

Microbiology Society Conference 2023 Tuberculosis: The forgotten pandemic

April 12, 2023
The Microbiology Society Annual Conference 2023 will take place 17 -20 April 2023 at Birmingham International Convention Centre.
1 2 3 Next »

developers of phage-based diagnostics

Contact Us
BIVDA member 2023

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!